Harmony Biosciences Holdings, Inc. (HRMY) — Stock Score Summary

Harmony Biosciences Holdings, Inc. (HRMY) has a MoatMap StockRank of 97/100 based on Quality (80/100), Value (64/100), and Momentum (46/100) factor scores. The current signal is STRONG BUY. Harmony Biosciences, a biopharmaceutical company focused on rare neurological diseases, aligns perfectly with the 'Specialty Pharma & Biotech Growth' theme, featuring strong IP, high ROIC potential, an asset-light commercial model, and addressing significant unmet medical needs.

Harmony Biosciences Holdings, Inc. is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients suffering from rare neurological diseases. With its flagship product WAKIX for narcolepsy already commercialized, the company establishes a strong market position by addressing significant unmet medical needs within niche neurological disorder markets.

Key Financial Metrics

Price$30.76
Market Cap$1.7B
P/E (TTM)12.13
P/E (Forward)5.39
Price/Book1.91
Return on Equity17.9%
Return on Invested Capital22.5%
Debt/Equity18.08
Gross Margin76.5%
Operating Margin17.3%
Revenue Growth16.6%
Free Cash Flow$150M

Harmony Biosciences Holdings, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Harmony Biosciences Holdings, Inc.’s (HRMY) StockRank?
MoatMap’s StockRank for Harmony Biosciences Holdings, Inc. (HRMY) is 97/100, with a Strong Buy signal. It is a composite of Quality (80), Value (64), and Momentum (46) factor ranks across MoatMap’s 19,000+ stock universe.
Does Harmony Biosciences Holdings, Inc. have an economic moat?
Harmony Biosciences Holdings, Inc. (HRMY) has a Quality factor score of 80/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Harmony Biosciences Holdings, Inc. a buy, hold, or sell?
MoatMap’s current signal for Harmony Biosciences Holdings, Inc. (HRMY) is Strong Buy, based on a StockRank of 97/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Harmony Biosciences Holdings, Inc. in?
Harmony Biosciences Holdings, Inc. (HRMY) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksHRMY deep dive reportAI ChampionsHow we score stocksSense-check another stock